THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
Identifieur interne : 000202 ( 1957/Analysis ); précédent : 000201; suivant : 000203THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
Auteurs : Margaret Tisdale [Royaume-Uni] ; D. J. Bauer [Royaume-Uni]Source :
- Annals of the New York Academy of Sciences [ 0077-8923 ] ; 1977-05.
Descripteurs français
- KwdFr :
- Adamantane (analogues et dérivés), Adamantane (pharmacologie), Amantadine (pharmacologie), Amines (pharmacologie), Animaux, Antiviraux (pharmacologie), Antiviraux (usage thérapeutique), Cellules cultivées, Cycloparaffines (pharmacologie), Infections à Orthomyxoviridae (traitement médicamenteux), Ribavirine (pharmacologie), Souris, Tests de sensibilité microbienne, Virus de la grippe A ().
- MESH :
- analogues et dérivés : Adamantane.
- pharmacologie : Adamantane, Amantadine, Amines, Antiviraux, Cycloparaffines, Ribavirine.
- traitement médicamenteux : Infections à Orthomyxoviridae.
- usage thérapeutique : Antiviraux.
- Animaux, Cellules cultivées, Souris, Tests de sensibilité microbienne, Virus de la grippe A.
English descriptors
- KwdEn :
- Adamantane (analogs & derivatives), Adamantane (pharmacology), Amantadine (pharmacology), Amines (pharmacology), Animals, Antiviral Agents (pharmacology), Antiviral Agents (therapeutic use), Cells, Cultured, Cycloparaffins (pharmacology), Influenza A virus (drug effects), Mice, Microbial Sensitivity Tests, Orthomyxoviridae Infections (drug therapy), Ribavirin (pharmacology).
- MESH :
- chemical , analogs & derivatives : Adamantane.
- chemical , pharmacology : Adamantane, Amantadine, Amines, Antiviral Agents, Cycloparaffins, Ribavirin.
- chemical , therapeutic use : Antiviral Agents.
- drug effects : Influenza A virus.
- drug therapy : Orthomyxoviridae Infections.
- Animals, Cells, Cultured, Mice, Microbial Sensitivity Tests.
Url:
DOI: 10.1111/j.1749-6632.1977.tb21958.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000438
- to stream Istex, to step Curation: 000438
- to stream Istex, to step Checkpoint: 001663
- to stream PubMed, to step Corpus: 000634
- to stream PubMed, to step Curation: 000634
- to stream PubMed, to step Checkpoint: 000543
- to stream Ncbi, to step Merge: 000D34
- to stream Ncbi, to step Curation: 000D34
- to stream Ncbi, to step Checkpoint: 000D34
- to stream Main, to step Merge: 002C46
- to stream Main, to step Curation: 002A85
- to stream Main, to step Exploration: 002A85
- to stream 1957, to step Extraction: 000202
Links to Exploration step
ISTEX:AC60933597E91FBED3562DB74366744F1F57A6C2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS</title><author><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name></author><author><name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AC60933597E91FBED3562DB74366744F1F57A6C2</idno><date when="1977" year="1977">1977</date><idno type="doi">10.1111/j.1749-6632.1977.tb21958.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-4HDHZ5SQ-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000438</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000438</idno><idno type="wicri:Area/Istex/Curation">000438</idno><idno type="wicri:Area/Istex/Checkpoint">001663</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001663</idno><idno type="wicri:doubleKey">0077-8923:1977:Tisdale M:the:relative:potencies</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:280137</idno><idno type="wicri:Area/PubMed/Corpus">000634</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000634</idno><idno type="wicri:Area/PubMed/Curation">000634</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000634</idno><idno type="wicri:Area/PubMed/Checkpoint">000543</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000543</idno><idno type="wicri:Area/Ncbi/Merge">000D34</idno><idno type="wicri:Area/Ncbi/Curation">000D34</idno><idno type="wicri:Area/Ncbi/Checkpoint">000D34</idno><idno type="wicri:doubleKey">0077-8923:1977:Tisdale M:the:relative:potencies</idno><idno type="wicri:Area/Main/Merge">002C46</idno><idno type="wicri:Area/Main/Curation">002A85</idno><idno type="wicri:Area/Main/Exploration">002A85</idno><idno type="wicri:Area/1957/Extraction">000202</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS</title><author><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name><affiliation wicri:level="2"><country>Royaume-Uni</country><placeName><region type="country">Angleterre</region></placeName><wicri:cityArea>Wellcome Research Laboratories Beckenham</wicri:cityArea></affiliation></author><author><name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name><affiliation wicri:level="2"><country>Royaume-Uni</country><placeName><region type="country">Angleterre</region></placeName><wicri:cityArea>Wellcome Research Laboratories Beckenham</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Annals of the New York Academy of Sciences</title><title level="j" type="alt">ANNALS OF NEW YORK ACADEMY SCIENCES</title><idno type="ISSN">0077-8923</idno><idno type="eISSN">1749-6632</idno><imprint><biblScope unit="vol">284</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="254">254</biblScope><biblScope unit="page" to="263">263</biblScope><biblScope unit="page-count">10</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1977-05">1977-05</date></imprint><idno type="ISSN">0077-8923</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0077-8923</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adamantane (analogs & derivatives)</term><term>Adamantane (pharmacology)</term><term>Amantadine (pharmacology)</term><term>Amines (pharmacology)</term><term>Animals</term><term>Antiviral Agents (pharmacology)</term><term>Antiviral Agents (therapeutic use)</term><term>Cells, Cultured</term><term>Cycloparaffins (pharmacology)</term><term>Influenza A virus (drug effects)</term><term>Mice</term><term>Microbial Sensitivity Tests</term><term>Orthomyxoviridae Infections (drug therapy)</term><term>Ribavirin (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adamantane (analogues et dérivés)</term><term>Adamantane (pharmacologie)</term><term>Amantadine (pharmacologie)</term><term>Amines (pharmacologie)</term><term>Animaux</term><term>Antiviraux (pharmacologie)</term><term>Antiviraux (usage thérapeutique)</term><term>Cellules cultivées</term><term>Cycloparaffines (pharmacologie)</term><term>Infections à Orthomyxoviridae (traitement médicamenteux)</term><term>Ribavirine (pharmacologie)</term><term>Souris</term><term>Tests de sensibilité microbienne</term><term>Virus de la grippe A ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adamantane</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Adamantane</term><term>Amantadine</term><term>Amines</term><term>Antiviral Agents</term><term>Cycloparaffins</term><term>Ribavirin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Adamantane</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Adamantane</term><term>Amantadine</term><term>Amines</term><term>Antiviraux</term><term>Cycloparaffines</term><term>Ribavirine</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Cells, Cultured</term><term>Mice</term><term>Microbial Sensitivity Tests</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Cellules cultivées</term><term>Souris</term><term>Tests de sensibilité microbienne</term><term>Virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Royaume-Uni</li></country><region><li>Angleterre</li></region></list><tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Tisdale, Margaret" sort="Tisdale, Margaret" uniqKey="Tisdale M" first="Margaret" last="Tisdale">Margaret Tisdale</name></region><name sortKey="Bauer, D J" sort="Bauer, D J" uniqKey="Bauer D" first="D. J." last="Bauer">D. J. Bauer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/1957/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000202 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/1957/Analysis/biblio.hfd -nk 000202 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= 1957
|étape= Analysis
|type= RBID
|clé= ISTEX:AC60933597E91FBED3562DB74366744F1F57A6C2
|texte= THE RELATIVE POTENCIES OF ANTI‐INFLUENZA COMPOUNDS
}}
| This area was generated with Dilib version V0.6.33. |  |